drugset / Trial / NCT00035048

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)

NCT00035048

Phase 3 Completed 540 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

A clinical study to determine the efficacy and safety of an investigational medication (MK0869) in the treatment of depression.

Timeline

Start
2001-11-21
Primary completion
2003-12-29
Completion
2003-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Aprepitant Other / unclassified